• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A T-cell stimulatory protein and interleukin-10 synergize to prevent gut inflammation

Bioengineer by Bioengineer
March 25, 2021
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This study will aid the understanding of, and future research on, inflammatory bowel disease, which afflicts about 1.6 million Americans

IMAGE

Credit: UAB

BIRMINGHAM, Ala. – Researchers have found an unexpected synergy between a T-cell stimulatory protein — the ICOS ligand — and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice. The study will aid the understanding of, and future research into, this immune disorder, which includes Crohn’s disease and ulcerative colitis. About 1.6 million Americans have inflammatory bowel disease.

Interleukin-10, or IL-10, was already known as a major player to prevent gut inflammation by establishing and maintaining immune homeostasis in the gut, where it is vital for the host to have a peaceful coexistence with normal intestinal microbes, while the immune system still stands guard against pathogens. IL-10 is produced by CD4+ T-regulatory cells in the gut.

ICOS ligand, or ICOSL, is expressed on B cells and dendritic cells of the immune system, and it helps to control T-cell activation and differentiation, two steps of the host immune response to microbes and microbial pathogens. Both IL-10 and ICOSL were known risk alleles for inflammatory bowel disease, but their synergistic interaction was not known.

The research, published in the Proceedings of the National Academy of Sciences, was led by Craig Maynard, Ph.D., assistant professor in the University of Alabama at Birmingham Department of Pathology.

“Collectively, our data identify a synergy between two inflammatory bowel disease-related pathways — T-cell-derived IL-10 and ICOSL-dependent anti-commensal antibodies — that promotes mutualism with the gut microbiota,” Maynard said. “Furthermore, we identify ICOSL deficiency as an effective platform for exploring the functions of anti-commensal antibodies in host-microbiota mutualism.”

In humans, complete deficiency of ICOSL or the ICOS receptor that ICOSL bind to causes a combined immunodeficiency with repeated bacterial and viral infections. In contrast, mice with ICOSL or ICOS receptor deficiencies maintain a healthy gut homeostasis under specific pathogen-free conditions.

In the current study, the UAB researchers found that ICOSL-deficient mice — like the ICOS receptor-deficient mice Maynard’s group has previously studied — harbored increased frequencies and numbers of IL-10-producing CD4+ T cells, particularly in the proximal colon.

When researchers transiently depleted the IL-10-producing cells in the ICOSL-deficient mice, they saw a striking change — rapid onset of severe inflammation in the proximal colon.

While the number of IL-10-producing CD4+ T cells was increased in the ICOSL-deficient mice, the numbers of colon-associated T-follicular helper cells and the plasma cells that produce immunoglobulin A and immunoglobulin G, or IgA and IgG respectively, were decreased.

The mice also had dramatic reductions in antibodies against normal gut microbes, which included a limited recognition of antigens implicated in the progression of inflammatory bowel disease. These included flagellin antigens derived from several members of the family Lachnospiraceae. These bacteria are known to enrich in the mucus-associated communities of the gut, and Crohn’s disease patients have antibodies against two of the Lachnospiraceae flagellin antigens. The mice also had reduced IgA and IgG antibodies that targeted antigens from multiple species of anaerobic bacteria known to be associated with active inflammatory bowel disease.

Simultaneous ablation of both pathways, ICOSL and IL-10, in newborn mice caused severe colitis with evidence of disease as early as four weeks, if the mice were fostered with ICOSL-deficient dams. However, this early onset intestinal inflammation was delayed when the newborn mice were fostered by ICOSL-sufficient dams, showing a protective role for maternal antibodies.

Maynard says the overall results suggest that induction of ICOSL-dependent antibodies and T-cell-derived IL-10 may be simultaneous host adaptations to microbial occupation of a niche near the epithelium in the gut. “Future exploration of the specific microbes that drive these responses,” he said, “could potentially identify novel antigen-specific approaches to bolster mucosal immune defenses.”

###

Co-authors with Maynard on the study, “ICOS ligand and IL-10 synergize to promote host-microbiota mutualism,” are Ashley E. Landuyt, Barbara J. Klocke, Rachel Q. Muir, Melissa S. Jennings and Goo Lee, UAB Department of Pathology; Lennard W. Duck and Charles O. Elson, Division of Gastroenterology and Hepatology, UAB Department of Medicine; Keri M. Kemp, Division of Nephrology, UAB Department of Medicine; Samuel I. Blum and Hubert M. Tse, UAB Department of Microbiology; and Casey D. Morrow, UAB Department of Cell, Developmental and Integrative Biology.

Support came from National Institutes of Health grants DK118386, AI007051 and GM088010; Crohn’s and Colitis Foundation Research Initiatives Award 558420; and the University of Alabama at Birmingham Microbiome Center.

Media Contact
Jeff Hansen
[email protected]

Original Source

https://www.uab.edu/news/research/item/11924-a-t-cell-stimulatory-protein-and-interleukin-10-synergize-to-prevent-gut-inflammation

Related Journal Article

http://dx.doi.org/10.1073/pnas.2018278118

Tags: GastroenterologyImmunology/Allergies/AsthmaInternal MedicineMedicine/HealthMicrobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Designing Thiadiazole β-Carboline Derivatives as Glucosidase Inhibitors

October 6, 2025

Mycoplasma Pneumoniae Linked to Neuromyelitis Optica Case

October 6, 2025

Innovative Modeling for Transcriptomics in FFPE Samples

October 6, 2025

Understanding Healthcare Providers’ Role in Reproductive Coercion

October 6, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Designing Thiadiazole β-Carboline Derivatives as Glucosidase Inhibitors

Mycoplasma Pneumoniae Linked to Neuromyelitis Optica Case

Innovative Modeling for Transcriptomics in FFPE Samples

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.